*\* indicates corresponding author*

-   **C. Jiang\***, D. Talbot, S. Carazo, and M.E. Schnitzer (2025). **A Double Machine Learning Approach for the Evaluation of COVID-19 Vaccine Effectiveness under the Test-Negative Design: Analysis of Québec Administrative Data**. *Statistics in Medicine, 44(5)*. [[Paper]](https://onlinelibrary.wiley.com/doi/full/10.1002/sim.70025)

-   **C. Jiang\***, M.P. Wallace, and M.E. Thompson (2023). **Dynamic Treatment Regimes with Interference**. *Canadian Journal of Statistics, 51(2): 469–502*. [[Paper]](https://onlinelibrary.wiley.com/doi/abs/10.1002/cjs.11702) [[Lay abstract]](https://www.statisticsviews.com/article/lay-abstract-for-canadian-journal-of-statistics-article-dynamic-treatment-regimes-with-interference/) (**This paper won the Canadian Journal of Statistics Award, Statistical Society of Canada,** [Link](https://ssc.ca/en/awards/2024/cong-jiang-michael-wallace-and-mary-thompson-canadian-journal-statistics-award-2024))

-   **C. Jiang**, M.E. Thompson\*, M.P. Wallace (2024). **Estimating dynamic treatment regimes for ordinal outcomes with household interference: Application in household smoking cessation**. *Statistical Methods in Medical Research, 33(6): 981–995*. [[Paper]](https://journals.sagepub.com/doi/10.1177/09622802241242313)

-   E.O. Brizuela, M. Carabali, **C. Jiang**, J. Merckx, D. Talbot, M.E. Schnitzer\* (2025). **Potential Biases in Test-Negative Design Studies of COVID-19 Vaccine Effectiveness Arising from the Inclusion of Asymptomatic Individuals**. *American Journal of Epidemiology, 194(3): 844–856*. [[Paper]](https://doi.org/10.1093/aje/kwae288)

-   C. Hong, L. Qin\*, **C. Jiang**, M. Qin, Y. Sun, J. Luo (2023). **Characteristics, risk management and GMP standards of pharmaceutical companies in China**. *Frontiers in Public Health 11:1103555*. [[Paper]](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031010/)

-   M. Mésidor, Y. Liu, D. Talbot, D. Skowronski, G.D. Serres, J. Merckx, A. Koushik, M. Tadrous, S. Carazo, **C. Jiang**, M.E. Schnitzer\* (2023). **Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: a systematic methodology review**. *Vaccine, 42(5)*. [[Paper]](https://www.sciencedirect.com/science/article/pii/S0264410X23014469)

-   E.S. Munroe, A. Spicer, ..., **C. Jiang**, ..., M. Semler, and E.C. Goligher\* (2024). **Evidence-Based Personalised Medicine in Critical Care: A Framework for Quantifying and Applying Individualised Treatment Effects in Critically Ill Patients**. *Lancet Respiratory Medicine, In press*. [[Paper]](https://doi.org/10.1016/S2213-2600%2825%2900054-2)

#### Under Review

-   **C. Jiang**, M.P. Wallace, and M.E. Thompson (2024). **Doubly Robust Dynamic Treatment Regimen Estimation for Binary Outcomes: two-step weighted generalized linear models**. Revise & Resubmit, *Canadian Journal of Statistics*. [[arXiv]](https://arxiv.org/abs/2203.08269)

-   **C. Jiang**, F. Fang, D. Talbot, M.E. Schnitzer. **Estimating Direct and Spillover Vaccine Effectiveness with Partial Interference under Test-Negative Design Sampling**. [[arXiv]](https://www.medrxiv.org/content/10.1101/2025.02.24.25322826v1)

#### In Preparation

-   **C. Jiang**, M.D. Hughes, and N. Hejazi. **Causal Mediation Analysis with Informative Censored Mediators**. [[Draft]](#)

-   E.O. Brizuela, **C. Jiang**, M. Carabali, D. Talbot, M.E. Schnitzer. **Machine Learning in Vaccine Effectiveness Estimation under the Test-Negative Design: Bridging the Gap for Epidemiologists**. [[Draft]](#)

-   H. Bian, **C. Jiang**, D. Talbot, M.E. Schnitzer. **Addressing Selection Bias and Time-Varying Confounders in Test-Negative Designs for Vaccine Effectiveness Studies**. [[Draft]](#)
